Full Text View
Tabular View
No Study Results Posted
Related Studies
Sevoflurane Versus Intravenous Anaesthetic Agents in Morbid Obese Patients
The recruitment status of this study is unknown because the information has not been verified recently.
Verified March 2010 by University of Patras.
Recruitment status was  Recruiting
Study NCT01279499   Information provided by University of Patras

First Received on January 11, 2011.   Last Updated on January 19, 2011   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Morbid Obesity
Additional conditions recognized in this trial
Obesity
Obesity, Morbid
More general conditions related to this trial
Body Weight
Nutrition Disorders
Overnutrition
Overweight
Signs and Symptoms
Interventions listed in this trial
Sevoflurane
Propofol- Remifentanyl
Propofol, Remifentanyl
Additional drug interventions recognized in this trial
Anesthetics
Anesthetics, Intravenous
Propofol
Remifentanil
Succinylcholine
More general drug interventions related to this trial
Analgesics
Analgesics, Opioid
Anesthetics, General
Anesthetics, Inhalation
Central Nervous System Agents
Central Nervous System Depressants
Hematologic Agents
Hypnotics and Sedatives
Neuromuscular Agents
Neuromuscular Blocking Agents
Neuromuscular Depolarizing Agents
Peripheral Nervous System Agents
Pharmacologic Actions
Physiological Effects of Drugs
Platelet Aggregation Inhibitors
Sensory System Agents
Therapeutic Uses
Sponsors listed in this trial
University of Patras


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services